Relationship between Helicobacter pylori Infections in Diabetic Patients and Inflammations, Metabolic Syndrome, and Complications

Table 4

The factors affecting the rate of H. pylori eradication.

Variables	Total	Those eradicated	Those not eradicated	value
Gender
Female	34	25 (73.5%)	9 (26.5%)	NS
Male	37	29 (78.3%)	8 (21.7%)
Age	48.7 ± 12.1	48.1 ± 13.3	50.8 ± 7.2	NS
Body mass index
Normal	12	12 (100%)	0 (0%)
Overweight	31	28 (90.3%)	3 (9.7%)
Obese^*	28	14 (50%)	14 (50%)	<0.05
Waistline^*	95.7 ± 10	94.3 ± 9.8	100 ± 9.4	<0.05
Hypertension
Yes^*	34	22 (64.7%)	12 (35.3%)	<0.05
No	37	32 (86.4%)	5 (13.6%)
Cholesterol
≥200^*	38	24 (63.1%)	14 (36.9%)	<0.05
<200	33	30 (90.9%)	3 (9.1%)
Triglyceride
≥150^*	30	19 (63.3%)	11 (36.7%)	<0.05
<150	41	35 (85.3%)	6 (14.7%)
Low density lipoprotein				NS
≥100	51	37 (72.5%)	14 (27.5%)
<100	20	17 (85%)	3 (15%)
High density lipoprotein				NS
Male ≥40, female ≥50	47	38 (80.8%)	9 (19.2%)
Male <40, female <50	24	16 (66.6%)	8 (33.4%)
Glucose^*	117 ± 42	110 ± 39	140 ± 41	<0.05
Patient groups
DM^*	40	25 (62.5%)	15 (37.5%)	<0.05
Non-DM	31	29 (93.5%)	2 (6.5%)

^*Significant variables.